Tom Milicevic

Biography

  Tom Milicevic has been Chief Financial Officer, Company Secretary of Oncosil Medical Ltd since July 25, 2017. He was appointed Chief Financial Officer, Joint Company Secretary on October 22, 2015. Mr Milicevic is a vastly experienced commercial, financial and management accountant with more than 20 years’ experience in a career which includes a number of major Australian and international public companies. He has specific financial expertise in medical device and biotech companies and his appointment represents a pivotal hire for the Company as it transitions from a development focus to the commercialisation of its OncoSilTM localised radiation treatment for cancer. Prior to joining OncoSil Medical Mr Milicevic was CEO and CFO of orthopaedic medical device company, Allegra Orthopaedics Limited (ASX: AMT) and led the company through its IPO and ASX listing in 2007. Mr Milicevic was also CFO for Babcock & Brown Residential Land Partners, an ASX listed fund, where he was the financial lead on the stapled security’s $175m IPO. His previous roles include CFO and Company Secretary with ASX listed oncology-focused biotech company Avantogen Limited, until it relocated to the US, and senior finance and accounting roles with Cochlear Ltd, Boral Ltd and Smorgon Steel Group Ltd. He is a qualified Certified Practising Accountants (CPA) and a Fellow of the Australian Society of CPA’s. He also has a Bachelor of Commerce.  

Research Interest

 finance oncology business and administration